Medtronic PLC
NYSE:MDT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medtronic PLC
NYSE:MDT
|
IE |
|
Spok Holdings Inc
NASDAQ:SPOK
|
US |
|
Northern Trust Corp
NASDAQ:NTRS
|
US |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
US |
|
FedEx Corp
NYSE:FDX
|
US |
|
T
|
Tieling Newcity Investment Holding Group Ltd
SZSE:000809
|
CN |
|
Annaly Capital Management Inc
NYSE:NLY
|
US |
|
Vaxart Inc
NASDAQ:VXRT
|
US |
|
China Merchants Bank Co Ltd
SSE:600036
|
CN |
|
Riverview Bancorp Inc
NASDAQ:RVSB
|
US |
|
GFL Environmental Inc
TSX:GFL
|
CA |
|
Quantum Computing Inc
NASDAQ:QUBT
|
US |
|
EverQuote Inc
NASDAQ:EVER
|
US |
Wall St Price Targets
MDT Price Targets Summary
Medtronic PLC
According to Wall Street analysts, the average 1-year price target for MDT is 109.66 USD with a low forecast of 90.9 USD and a high forecast of 127.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MDT's stock price target?
Price Target
109.66
USD
According to Wall Street analysts, the average 1-year price target for MDT is 109.66 USD with a low forecast of 90.9 USD and a high forecast of 127.05 USD.
What is the Revenue forecast for Medtronic PLC?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 5 years is 5%.
What is the Operating Income forecast for Medtronic PLC?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 5 years is 13%.
What is the Net Income forecast for Medtronic PLC?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 5 years is 16%.
